Ginsenoside Rg3 Ameliorates Psoriasis‐Like Dermatitis through Inhibition of NF‐κB/NLRP3 Inflammasome Signaling and Regulating Th17/Treg Balance

Liyun Gao(Bengbu Medical College), Congjun Jiang(First Affiliated Hospital of Bengbu Medical College)

Immunity Inflammation and Disease

February 1, 2026

10.1002/iid3.70362

Cited by 0

Related Papers

A multicentre randomized double-blind placebo-controlled phase III study of the efficacy and safety of xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis

|British Journal of Dermatology|2024|21